Androgen deprivation therapy fails to affect telomere length in prostate cancer

Men with non-metastatic prostate cancer who received androgen deprivation therapy for 2 years saw no change in leukocyte telomere length when compared with controls who received radiotherapy, according to findings from a case-control study in Australia.
Healio